Bal Dit Sollier C - Search Results

1

Effect of milk fat on LDL cholesterol and other cardiovascular risk markers in healthy humans: the INNOVALAIT project.

Bard JM, Drouet L, Lairon D, Cazaubiel M, Marmonier C, Ninio E, Bal Dit Sollier C, Martin JC, Boyer C, Bobin-Dubigeon C; INNOVALAIT Study group. Bard JM, et al. Among authors: bal dit sollier c. Eur J Clin Nutr. 2020 Feb;74(2):285-296. doi: 10.1038/s41430-019-0528-4. Epub 2019 Nov 11. Eur J Clin Nutr. 2020. PMID: 31712768 Clinical Trial.

2

Role of serotonin in arteriolar thrombosis and secondary vasospasm.

Drouet L, Bal Dit Sollier C, Ruton S, Pignaud G. Drouet L, et al. Among authors: bal dit sollier c. J Cardiovasc Pharmacol. 1990;16 Suppl 3:S49-53. J Cardiovasc Pharmacol. 1990. PMID: 1369719

3

[Anti-thrombotic effect of lacto-transferrin peptides].

Bal Dit Sollier C, Drouet L, Fiat AM, Jolles P, Caen JP. Bal Dit Sollier C, et al. C R Seances Soc Biol Fil. 1990;184(3-4):201-10. C R Seances Soc Biol Fil. 1990. PMID: 2151312 French. No abstract available.

4

The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.

Drouet L, Bal dit Sollier C, Cisse M, Pignaud G, Mazoyer E, Fiat AM, Jolles P, Caen JP. Drouet L, et al. Among authors: bal dit sollier c. Nouv Rev Fr Hematol (1978). 1990;32(1):59-62. Nouv Rev Fr Hematol (1978). 1990. PMID: 2349083

5

Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities.

Fiat AM, Migliore-Samour D, Jollès P, Drouet L, Bal dit Sollier C, Caen J. Fiat AM, et al. Among authors: bal dit sollier c. J Dairy Sci. 1993 Jan;76(1):301-10. doi: 10.3168/jds.s0022-0302(93)77351-8. J Dairy Sci. 1993. PMID: 8436680 Review.

6

Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?

Andre P, Bal dit Sollier C, Bonneau M, Pignaud G, Hainaud P, Azzam K, Drouet L. Andre P, et al. Among authors: bal dit sollier c. Haemostasis. 1996 Oct;26 Suppl 4:55-69. doi: 10.1159/000217286. Haemostasis. 1996. PMID: 8979112 Review.

7

[What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?].

André P, Bal dit Sollier C, Bonneau M, Pignaud G, Hainaud P, Azzam K, Drouet L. André P, et al. Among authors: bal dit sollier c. Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1461-70. Arch Mal Coeur Vaiss. 1996. PMID: 9092404 Review. French.

8

Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.

André P, Brouland JP, Roussi J, Bonneau M, Pignaud G, Bal dit Sollier C, Hainaud P, Vaiman M, Drouet L. André P, et al. Among authors: bal dit sollier c. Exp Hematol. 1998 Jul;26(7):620-6. Exp Hematol. 1998. PMID: 9657137

9

Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease.

Roussi J, Turecek PL, André P, Bonneau M, Pignaud G, Bal dit Sollier C, Schlokat U, Dorner F, Schwarz HP, Drouet L. Roussi J, et al. Among authors: bal dit sollier c. Blood Coagul Fibrinolysis. 1998 Jun;9(4):361-72. doi: 10.1097/00001721-199806000-00009. Blood Coagul Fibrinolysis. 1998. PMID: 9690808

10

[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].

Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L. Drouet L, et al. Among authors: bal dit sollier c. Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:41-51. Arch Mal Coeur Vaiss. 1998. PMID: 9833079 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page